Xilio Therapeutics is a clinical-stage biotechnology company focused on discovering and developing masked immuno-oncology therapies designed to selectively activate within the tumor microenvironment, improving outcomes for cancer patients while minimizing systemic side effects
Xilio Therapeutics is a clinical-stage biotechnology company focused on discovering and developing masked immuno-oncology therapies designed to selectively activate within the tumor microenvironment, improving outcomes for cancer patients while minimizing systemic side effects.